Shockwave Medical
Shockwave Medical, part of Johnson & Johnson MedTech, is a leader in the development and commercialization of innovative products that are transforming the treatment of cardiovascular disease. Its first-of-its-kind Intravascular Lithotripsy (IVL) technology has transformed the treatment of atherosclerotic cardiovascular disease by using sonic pressure waves to disrupt challenging calcified plaque, resulting in significantly improved patient outcomes. Its Reducer technology, which is under clinical investigation in the United States and is CE Marked in the European Union and the United Kingdom, is designed to provide relief to the millions of patients worldwide suffering from refractory angina by redistributing blood flow within the heart. Learn more at www.shockwavemedical.com.
10 seconds
Playback speed
Shockwave L6 in Action: Calcified Bilateral Iliacs – Changing Compliance for Large Bore Access
|
Frank Arko III, MD, Chief of Vascular and Endovascular Surgery at Sanger Heart and Vascular Institute, Artium Health in Charlotte, North Carolina discusses Shockwave L6 case with Joseph V. Lombardi, MD, FACS, Chief of Vascular and Endovascular Surgery at Cooper University Hospital in Camden, New Jersey. Shockwave IVL Important Safety Information: https://shockwavemedical.com/important-safety-information-universal/ |
